Innovative Health Initiative, the partnership for health research and innovation between the EU and Europe’s life science industries, will organise the event « Impact on cancer, How IHI and IMI projects are tackling cancer ». The webinar will take place on May 19, 10:30 – 12:00 UTC, and will explore some of the highlights from several IHI and former IMI projects focused on cancer:
- PIONEER used big data to address key knowledge gaps related to the screening, diagnosis and treatment of prostate cancer patients.
- OPTIMA is harnessing the power of AI to advance treatments and facilitate decision-making for physicians and patients with prostate, breast and lung cancer.
- CANCER-ID advanced the science that will lead to more widespread use of liquid biopsy (a blood test that detects signs of cancerous tumors, including tumor cells and cancer cell DNA in the blood) in clinical trials of cancer drugs, and in the clinical treatment of patients with cancer.
- GUIDE-MRD is exploring how blood tests could be used to identify which patients might benefit from additional treatment, and which patients would likely not benefit from treatment.
- IMAGIO, a new IHI project that focuses on ‘interventional oncology’, which uses miniaturised instruments to target cancer cells more precisely, thereby sparing health cells.
More information >>
